Cell and gene therapies promise to transform patient outcomes by unlocking cures for diseases with high-unmet need. Yet, their complex nature presents therapy owners with unprecedented challenges across logistics, commercialization, market access, and reimbursement that threaten to derail a product’s success.

In this white paper, market-leading experts from AmerisourceBergen, TrakCel and Invetech propose action-oriented solutions to cell and gene therapy commercialization, including what it takes to design and execute an effective commercialization strategy.

Download this white paper for key takeaways related to:

  • cGMP manufacturing
  • Securing regulatory approval
  • Integrating supply chain and logistics strategy
  • Critical success factors for market access
  • Creating a differentiated patient and provider experience
  • Managing payment and distribution

Authors & Contributors:

Download White Paper

The information you provide will be used in accordance with the terms of our privacy policy.

For more than 30 years, Invetech has provided full-spectrum product realization services to create breakthrough products and custom automation systems for companies across the globe. Our experience spans a broad range of market sectors, including laboratory diagnostics, point of care diagnostics, cell therapy, life sciences, industrial and consumer products.

Your Product Realization Partner
Let's discuss your next project.
Contact us

San Diego | Boxborough | Melbourne